Literature DB >> 7807167

Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings.

L Ferini-Strambi1, M Filippi, V Martinelli, A Oldani, M Rovaris, M Zucconi, G Comi, S Smirne.   

Abstract

It has been suggested that sleep disturbances in multiple sclerosis (MS) may be related to periodic leg movements (PLM) during sleep, but to date polysomnographic studies were conducted only on small and unselected patient groups. Aim of this study was to evaluate 8-hour polysomnography in MS patients and to correlate sleep results with clinical and brain magnetic resonance imaging (MRI) data. Twenty-five clinically definite MS patients, without mood disorders and drug-free, entered the study. The patients were compared to 25 age- and sex-matched subjects. MS patients had significantly reduced sleep efficiency and experienced more awakenings during sleep. No difference was found in sleep architecture parameters between MS patients and controls. PLM was found in 9 patients (36%) and 2 controls (8%; p = 0.02). Of the six patients who complained of insomnia two had PLM and 2 others presented with PLM and central sleep apnea. In patients with PLM greater MRI lesion loads were detected in the infratentorial regions, particularly in cerebellum and brainstem. Larger studies in neurological diseases that produce focal lesions in these brain areas could provide useful information on the PLM pathogenesis.

Entities:  

Mesh:

Year:  1994        PMID: 7807167     DOI: 10.1016/0022-510x(94)90035-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  34 in total

1.  Fatigue and sleep disorders in multiple sclerosis: is obstructive sleep apnea a link?

Authors:  Friedemann Paul; Christian Veauthier
Journal:  Sleep Breath       Date:  2012-01-18       Impact factor: 2.816

2.  Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study.

Authors:  Robert A Dias; Kimberly A Hardin; Heather Rose; Mark A Agius; Michelle L Apperson; Steven D Brass
Journal:  Sleep Breath       Date:  2012-01-21       Impact factor: 2.816

3.  Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Jeanne Maglione; Sonia Ancoli-Israel
Journal:  J Neurol Sci       Date:  2012-01-25       Impact factor: 3.181

4.  [Central sleep apnea in multiple sclerosis].

Authors:  A Steffen; J Hagenah; B Wollenberg; N Brüggemann
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

Review 5.  Sleep apnea in pediatric neurological conditions.

Authors:  Gabor Szuhay; Josh Rotenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

6.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

7.  Central sleep apnea in multiple sclerosis: a pilot study.

Authors:  Michael Lin; Arun V Krishnan; Danny J Eckert
Journal:  Sleep Breath       Date:  2016-12-14       Impact factor: 2.816

Review 8.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 9.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

10.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.